Creatine for Women: Same 3–5 g, Different Evidence Base
Informational summary of the ISSN position stand and published trials, not medical advice. If you are pregnant, breastfeeding, have kidney disease or take an antidepressant, the clinician managing your care has the final say on any supplement.
Quick answer
A woman does not need a different creatine, a different form or a different dose. It is the same molecule at the same 3–5 g of creatine monohydrate a day, and every trial that showed a benefit in women used plain monohydrate. What changes is which evidence matters to you: strength gains in women who lift, a small lean-mass effect that is real but smaller than in men, bone geometry rather than bone density after menopause, a trial of faster antidepressant response in women with depression, and no human data at all in pregnancy.
The “women’s creatine” shelf sells a smaller number, not a better one. We read 1,200 creatine labels filed with the NIH: monohydrate labels sit at a median 5 g per serving, the studied dose, while creatine HCl sits at 2 g and buffered creatine at 1.5 g. The forms marketed as gentler or “micro-dosed” are simply underdosed. See the census →
Already sold on monohydrate? See the best creatine picks ranked by cost per 5 g →
On this page
The dose table for women, by goal
The International Society of Sports Nutrition position stand puts the maintenance dose at 3–5 g of creatine monohydrate a day, with an optional loading week, and carries no footnote for sex (Kreider 2017, PMID: 28615996). The trials in women mostly dosed by body weight, which lands in the same range for a 55–70 kg woman and a little above it in the postmenopausal bone studies. The table gives the practical dose beside what each trial used.
| Goal | Practical dose | What the trials in women used | What they found |
|---|---|---|---|
| General health, not training | 3 g/day | 3 g/day for 2 years, 200 postmenopausal women with osteopenia, no exercise program (Sales 2020) | No effect on bone density, lean mass or muscle function. Creatine alone does not build anything. |
| Resistance training, premenopausal | 3–5 g/day; loading optional | 0.5 g per kg of fat-free mass for 5 days, 22 college-age women (Kambis 2003) · 20 g/day loading, 39 active women (Gordon 2023) | More quadriceps power in five days; no change in body weight or thigh circumference. Sprint fatigue improved most in the luteal phase. |
| Resistance training, after menopause | 5 g/day, with the training | 0.1 g/kg/day for 12 months (Chilibeck 2015) · 0.14 g/kg/day for 2 years, 237 women (Chilibeck 2023) | Slower femoral-neck bone loss at 12 months; at 2 years no density effect but better femoral geometry, faster walking and more lean mass in completers. |
| Strength and lean mass, 60+ | 5 g/day, with the training | Pooled trials, 608 postmenopausal women (Naddafha 2026); 24 weeks, 60 vulnerable older women (Gualano 2014) | +0.37 kg lean mass and +7.5 kg leg press with creatine at 5 g or more plus training; 3 g or less without training did nothing. |
| Mood, as an adjunct under psychiatric care | 5 g/day, only with the prescriber | 5 g/day added to escitalopram for 8 weeks, 52 women with major depression (Lyoo 2012) | Greater improvement on the Hamilton depression scale from week 2 onward. One trial, not a treatment. |
| Pregnancy or breastfeeding | No dose to give | No randomized trial exists (Dickinson 2014) | Animal data only. A decision for you and the clinician managing your care. |
Loading, timing, cycling and the body-weight calculator are on the creatine dosage guide. Nothing there changes for women.
What the evidence specifically in women says
Most creatine trials enrolled men, and most of what you read about creatine and women is extrapolated. The 2021 lifespan review put the gap plainly: women are understudied, the review reports women’s endogenous creatine stores as 70–80% lower than men’s, and hormonal shifts across the cycle, pregnancy and menopause change creatine kinetics in ways that have barely been tested (Smith-Ryan 2021, PMID: 33800439). The 2025 follow-up reaches the same place: early trials ignored the menstrual cycle, the strength and body-composition benefits hold when creatine is paired with resistance training, and the pregnancy and perimenopause data remain thin (Smith-Ryan 2025, PMID: 40371844). Both reviews list authors who advise a creatine manufacturer, and so do the ISSN position stand, the 2026 menopause meta-analysis and the animal-pregnancy review cited on this page; the primary trials cited here (Kambis, Chilibeck, Sales, Lyoo, Korovljev) are the ones to weigh. Below is what the primary trials show.
Muscle and strength: it works, and the lean-mass effect is smaller than in men
The performance effect in women was settled early. In 22 college-age women, five days of creatine loading cut time to peak quadriceps torque and raised average power in extension and flexion, with no change in fat-free mass, body fat, thigh circumference or body weight (Kambis 2003, PMID: 12660408). The muscle worked better without getting bigger.
The lean-mass effect is where honesty matters. A meta-analysis of 35 randomized trials and 1,192 participants found creatine raised lean body mass by 0.68 kg overall and by 1.10 kg when combined with resistance training. Split by sex, men gained 1.46 kg and women a non-significant 0.29 kg (Delpino 2022, PMID: 35986981). Creatine does not build muscle on its own in anyone; it lets you do slightly more work, and the muscle that follows is yours. In women that increment is small: expect strength before shape.
In older women the strength signal is clearer than the mass signal. Ten randomized trials in 211 older females found creatine plus resistance training increased upper-body strength, with lower-body strength improving in trials of at least 24 weeks and no effect on muscle mass (Dos Santos 2021, PMID: 34836013). In 60 vulnerable older women, creatine with training beat every other arm on bench press and appendicular lean mass; creatine without training did not (Gualano 2014, PMID: 24530883). Creatine multiplies training; it does not replace it.
Bone after menopause: geometry moves, density does not
This is the claim most often oversold to women over 50, so the trials deserve to be read in order. A 12-month trial randomized 47 postmenopausal women to 0.1 g/kg/day of creatine or placebo during supervised resistance training. Creatine slowed the loss of femoral-neck bone density (a 1.2% fall against 3.9% on placebo) and widened the femoral shaft, a predictor of bending strength; 33 women finished (Chilibeck 2015, PMID: 25386713). The same group then ran the definitive version: 237 postmenopausal women, 0.14 g/kg/day, resistance training three days a week plus walking six, for two years. Creatine had no effect on bone mineral density at the femoral neck, hip or spine. It did preserve section modulus and buckling ratio at the femoral neck, two geometric measures of resistance to bending, cut 80 m walking time, and in completers raised lean mass (Chilibeck 2023, PMID: 37144634).
Without the training, nothing happens. Two hundred postmenopausal women with osteopenia took 3 g/day of creatine or placebo for two years with no exercise program: bone density, microarchitecture, bone markers, falls, fractures, lean mass and muscle function were all unchanged, and the authors wrote that this “refutes the long-lasting notion that this dietary supplement alone has osteogenic or anabolic properties” (Sales 2020, PMID: 31257405). The 2026 meta-analysis of seven trials and 608 postmenopausal women pulls it together: lean mass up 0.37 kg and leg press up 7.5 kg when creatine at 5 g/day or more was combined with resistance training; 3 g/day or less without training showed no measurable effect; bone density unchanged; adverse events mild and no different from placebo (Naddafha 2026, PMID: 42141930). After menopause and lifting, creatine is a reasonable addition at 5 g. Not lifting, it is not a bone supplement.
Cognition and mood: one real trial in women, and it was an add-on
The brain buffers energy with creatine the way muscle does, and the cleanest cognition trial enrolled people with low dietary creatine. Forty-five young vegetarians took 5 g/day for six weeks in a crossover design and improved on backward digit span and Raven’s matrices, both speed-of-processing tasks (Rae 2003, PMID: 14561278). A meta-analysis of randomized trials in healthy people found a memory benefit, concentrated in older adults (Prokopidis 2023, PMID: 35984306). A separate systematic review was less impressed: supplementation raises brain creatine, but the cognitive results are equivocal (McMorris 2024, PMID: 38582412). The honest summary: a probable small effect on memory-type tasks, larger if your diet is low in creatine, and not a reason on its own to take it.
Mood is the one place the women-specific evidence is stronger than the general evidence, and it comes with a hard boundary. Fifty-two women with major depressive disorder were randomized to escitalopram plus 5 g/day of creatine or escitalopram plus placebo for eight weeks. The creatine group improved more on the Hamilton depression scale from week two, and the difference held at weeks four and eight, with no difference in dropouts or adverse events (Lyoo 2012, PMID: 22864465). An earlier open-label study gave 4 g/day to five adolescent girls with fluoxetine-resistant depression and saw scores fall 56%; no placebo, five participants (Kondo 2011, PMID: 21831448). The boundary: both studies added creatine to a prescribed antidepressant under psychiatric supervision. Neither tested creatine instead of treatment, and this page does not either.
Perimenopause and menopause: the symptom claims run ahead of the trials
The bone and muscle data above are the menopause evidence. For hot flashes, sleep, brain fog and mood swings, there is very little. The one randomized trial built for this question gave 36 perimenopausal and menopausal women eight weeks of creatine HCl at 750 mg/day, HCl at 1,500 mg/day, HCl plus creatine ethyl ester at 800 mg/day, or placebo, about nine women per arm. The 1,500 mg HCl group improved reaction time and frontal brain creatine against placebo, and the effect on mood-swing severity did not reach significance (Korovljev 2026, PMID: 40854087). It is a pilot that used the low-dose forms this page argues against and measured reaction time rather than symptoms, not the trial the “creatine for menopause” marketing implies exists.
Pregnancy: no human trial, and this page will not pretend otherwise
The placenta and fetus run the creatine kinase circuit, and animal models of maternal supplementation protect the fetal brain against low oxygen, which is why the question is live (Muccini 2021, PMID: 33540766). A Cochrane review set out to pool randomized trials of creatine in pregnant women and found none, completed or ongoing (Dickinson 2014, PMID: 25523279). The 2025 expert review on creatine misconceptions still carries “is creatine safe to consume during pregnancy” as an open question (Antonio 2025, PMID: 39720835). No dose is given here, and the same applies to breastfeeding, where no controlled trial exists at all. The clinician managing your pregnancy decides.
The menstrual cycle: one trial, one phase, one qualified result
Cycle-timed creatine is a popular claim with a single data point. Thirty-nine active women loaded 20 g/day of monohydrate or placebo and repeated sprint testing in the low-hormone and high-hormone phases. There was a phase-by-supplement interaction for fatigue index, with the largest improvement in the high-hormone phase on creatine, and the authors describe creatine’s ability to counteract the luteal performance dip as not statistically significant (Gordon 2023, PMID: 37630756). Take it daily; saturation is cumulative and the cycle is not.
Water, bulk, hair and kidneys: what the data say
Water. Creatine is osmotically active and pulls water into the muscle cell. The expert review on misconceptions finds the effect short-term, tied to loading, and not supported as long-term water retention at the 3–5 g/day recommended dose (Antonio 2021, PMID: 33557850). In the five-day loading study in women, body weight did not move (Kambis 2003). Water inside a muscle cell is not the puffiness people mean by bloating; it is the fuller look lifters pay for.
Bulk. The 0.29 kg non-significant lean-mass gain in women across 35 trials (Delpino 2022) is the answer. Creatine adds reps, and the tissue that follows is whatever your training and diet build. Visible bulk in a woman takes a sustained calorie surplus, years of progressive overload and a hormonal environment women do not have. Creatine contributes none of those.
Hair. The worry traces to one 2009 study in which 20 male rugby players loading 25 g/day showed a rise in dihydrotestosterone within the normal range (van der Merwe 2009, PMID: 19741313). The first trial to measure hair directly randomized 45 resistance-trained men to 5 g/day or placebo for 12 weeks and found no difference in DHT, testosterone, hair density, follicular count or hair thickness (Lak 2025, PMID: 40265319). Both studies are in men; no trial has measured hair in women, and no trial in women has reported an androgenic signal. Creatine is not a hormone.
Kidneys. Creatine raises serum creatinine because creatinine is what creatine turns into, and a creatinine reading is how kidney function is usually estimated. A meta-analysis of 12 studies found a small rise in serum creatinine with supplementation and no significant change in glomerular filtration rate, the measure that reflects kidney function (Naeini 2025, PMID: 41199218). In the 12-month postmenopausal trial, creatinine clearance stayed normal throughout (Chilibeck 2015). Tell whoever orders your bloodwork that you take creatine, so a raised creatinine is read correctly. If you have kidney disease, the ISSN safety data do not cover you; that decision belongs to your nephrologist.
We read 1,200 creatine labels: the women’s shelf sells a smaller dose, not a different one
Original research Every on-market creatine supplement label filed with the NIH Dietary Supplement Label Database (2,412 on the market, 1,200 read, 969 with a parseable creatine quantity, 788 with a daily direction), with the grams per serving taken from the Supplement Facts panel and the declared chemical form from the ingredient line.
The premise of “creatine for women” products is a gentler form at a smaller dose. The labels confirm the smaller dose and nothing about gentler. Creatine monohydrate labels sit at a median 5 g per serving, and the 90th percentile is 5 g: the form barely varies, and it varies around the studied dose (599 labels). Creatine HCl sits at a median 2 g (110 labels), buffered creatine at 1.5 g (43), magnesium creatine chelate at 0.6 g (39), and labels that name no form at 3 g (171). Those are the forms at the pastel-tub end of the market, and every one is sold below the 3–5 g the evidence supports for any form of creatine.
| Item | Value ( g) |
|---|---|
| Creatine monohydrate | 5 g |
| No form named | 3 g |
| Creatine HCl | 2 g |
| Buffered / Kre-Alkalyn | 1.5 g |
| Magnesium chelate | 0.6 g |
Two more things the labels show. First, the day’s dose runs a little above the scoop: the median label directs 3.5 g per day against a median 3 g per serving, because a share of labels direct more than one serving. Second, the census has no women’s split: the NIH database does not tag a label by intended sex and we did not build a subset by brand name, so the figures above are shelf-wide and no separate women’s population was censused. One women’s-branded label did surface in our front-of-pack check: Nutricost Women “Creatine 3 g Peach Mango” states 3 g on the front and 2.25 g on the Supplement Facts panel. That is one record, not a pattern, and it is the kind of label to read twice. Gummies barely appear in the NIH database at all, so this read cannot measure the gummy shelf; the creatine gummies guide handles it product by product.
Method: 1,200 labels retrieved from the NIH Dietary Supplement Label Database (DSLD) v9 on 2026-08-30 for the term “creatine” (2,412 on the market); 969 declare creatine with a parseable quantity and 788 carry a daily direction. Grams per serving is the panel quantity for the labeled serving; grams per day multiplies it by the maximum daily servings directed. Form is the declared chemical form in the ingredient line. Medians are stated against labels that declared a quantity, never against labels read. Every figure was recomputed in both halves of the read order: 2 of 4 findings held within tolerance, and the two that did not (whether most of the market sells above the typical dose, and the share selling above the studied range) are deliberately not published as numbers. What it cannot tell you: which products sell most, whether a scoop holds what the panel says, which labels are marketed to women, or anything about products not filed with the NIH.
The product links below go to Amazon and we may earn a commission if you buy. It never changes which product we pick or what we say about it. How we choose.
For most women: Optimum Nutrition Micronized Creatine Monohydrate (60 servings) $0.27/day is plain micronized monohydrate at 5 g a scoop, banned-substance tested, and the value pick on our best creatine ranking. Take 3–5 g a day and skip the loading week unless you have a deadline.
If you compete in a tested sport or want the tightest testing: Thorne Creatine (Creapure, 90 servings) $0.49/day is Creapure monohydrate with NSF Certified for Sport on the label. Same molecule, same dose, higher purity guarantee.
On a budget: NOW Sports Creatine Monohydrate Powder (600g) $0.20/day is the same monohydrate for less. What not to buy: a women’s-branded HCl, buffered or gummy product, priced as a premium and dosed as a fraction.
Frequently asked questions
Does creatine make women gain weight?
A small amount, early, and it is water inside the muscle rather than fat. A five-day loading study in 22 college-age women found no change in body weight, fat-free mass, body fat or thigh circumference. Across 35 trials, women on creatine gained a non-significant 0.29 kg of lean mass against 1.46 kg in men. If the scale moves in week one it is intramuscular water.
Does creatine cause bloating in women?
Loading doses (20 g a day split into four) can cause stomach upset and a short-term rise in body water. A steady 3–5 g a day does neither in most people, and the expert review on creatine misconceptions finds no evidence of long-term water retention at the recommended dose. If you are prone to bloating, skip loading and take one 3–5 g dose with a meal.
Should women do a loading phase?
Only if you have a deadline. Loading (about 20 g a day for 5–7 days) saturates muscle in roughly a week; 3–5 g a day reaches the same place in three to four weeks. The trials in women used both routes. Loading is where the early water weight and stomach complaints come from, so the steady dose is the better default.
Can I take creatine while breastfeeding?
There is no controlled trial of creatine supplementation in breastfeeding women, so no one can call it safe or unsafe from data. Creatine is a normal component of breast milk and of food, which is why it is generally treated as low-risk, but that is reasoning, not evidence. Ask the clinician managing your care.
Can I take creatine while pregnant?
No human trial has tested it. A Cochrane review looking for randomized trials of creatine in pregnancy found none, and the 2025 expert review on creatine misconceptions still lists pregnancy safety as an open question. The animal data are encouraging, which is why the question is being asked; they are not an answer. This page makes no recommendation for pregnancy.
Is there a best time in my cycle to take creatine?
The evidence is a single 39-woman trial. Sprint fatigue improved most when creatine loading fell in the high-hormone (luteal) phase, but the authors describe the effect on the luteal dip as not statistically significant. Take creatine every day and ignore the cycle.
Do I need a women's creatine, a gummy or creatine HCl?
No. There is no women's molecule. Creatine monohydrate is the form every trial in women used, and it is sold at a median 5 g per serving on the labels we read. Creatine HCl labels sit at a median 2 g and buffered creatine at 1.5 g, below the 3–5 g the evidence supports for any form. Gummies barely appear in the NIH label database at all. Buy plain monohydrate and check the grams.
Does creatine affect women's hormones or cause hair loss?
Creatine is not a hormone. The hair-loss worry comes from one 2009 study of 20 male rugby players whose DHT rose during loading; a 2025 randomized trial of 45 men found no change in DHT, testosterone or measured hair density after 12 weeks at 5 g a day. Neither study included women, no trial has measured hair in women, and no trial has shown an androgenic effect at any dose studied.
Related guides
- Creatine dosage guide: loading vs maintenance, timing, cycling, the body-weight calculator
- Best creatine overall: every monohydrate pick ranked by cost per 5 g
- Best creatine for women: the product ranking for this audience
- Monohydrate vs HCl: why the solubility argument does not change the dose
- Thorne vs Optimum Nutrition: Creapure and NSF against the value pick
- Creatine gummies: what a gummy actually delivers
- Vitamin D for women
- Iron for women
Sources
- Kreider RB, et al. "International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine." J Int Soc Sports Nutr. 2017;14:18. PMID: 28615996
- Smith-Ryan AE, et al. "Creatine Supplementation in Women's Health: A Lifespan Perspective." Nutrients. 2021;13(3):877. PMID: 33800439
- Smith-Ryan AE, et al. "Creatine in women's health: bridging the gap from menstruation through pregnancy to menopause." J Int Soc Sports Nutr. 2025;22(1):2502094. PMID: 40371844
- Kambis KW, Pizzedaz SK. "Short-term creatine supplementation improves maximum quadriceps contraction in women." Int J Sport Nutr Exerc Metab. 2003;13(1):87-96. PMID: 12660408
- Delpino FM, et al. "Influence of age, sex, and type of exercise on the efficacy of creatine supplementation on lean body mass: A systematic review and meta-analysis of randomized clinical trials." Nutrition. 2022;103-104:111791. PMID: 35986981
- Dos Santos EEP, et al. "Efficacy of Creatine Supplementation Combined with Resistance Training on Muscle Strength and Muscle Mass in Older Females: A Systematic Review and Meta-Analysis." Nutrients. 2021;13(11):3757. PMID: 34836013
- Gualano B, et al. "Creatine supplementation and resistance training in vulnerable older women: a randomized double-blind placebo-controlled clinical trial." Exp Gerontol. 2014;53:7-15. PMID: 24530883
- Chilibeck PD, et al. "Effects of Creatine and Resistance Training on Bone Health in Postmenopausal Women." Med Sci Sports Exerc. 2015;47(8):1587-95. PMID: 25386713
- Chilibeck PD, et al. "A 2-yr Randomized Controlled Trial on Creatine Supplementation during Exercise for Postmenopausal Bone Health." Med Sci Sports Exerc. 2023;55(10):1750-1760. PMID: 37144634
- Sales LP, et al. "Creatine Supplementation (3 g/d) and Bone Health in Older Women: A 2-Year, Randomized, Placebo-Controlled Trial." J Gerontol A Biol Sci Med Sci. 2020;75(5):931-938. PMID: 31257405
- Naddafha S, et al. "Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis." J Int Soc Sports Nutr. 2026;23(1):2668435. PMID: 42141930
- Rae C, et al. "Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial." Proc Biol Sci. 2003;270(1529):2147-50. PMID: 14561278
- Prokopidis K, et al. "Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials." Nutr Rev. 2023;81(4):416-427. PMID: 35984306
- McMorris T, et al. "Creatine supplementation research fails to support the theoretical basis for an effect on cognition: Evidence from a systematic review." Behav Brain Res. 2024;466:114982. PMID: 38582412
- Lyoo IK, et al. "A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder." Am J Psychiatry. 2012;169(9):937-945. PMID: 22864465
- Kondo DG, et al. "Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study." J Affect Disord. 2011;135(1-3):354-61. PMID: 21831448
- Korovljev D, et al. "The Effects of 8-Week Creatine Hydrochloride and Creatine Ethyl Ester Supplementation on Cognition, Clinical Outcomes, and Brain Creatine Levels in Perimenopausal and Menopausal Women (CONCRET-MENOPA): A Randomized Controlled Trial." J Am Nutr Assoc. 2026;45(3):199-210. PMID: 40854087
- Muccini AM, et al. "Creatine Metabolism in Female Reproduction, Pregnancy and Newborn Health." Nutrients. 2021;13(2):490. PMID: 33540766
- Dickinson H, et al. "Creatine for women in pregnancy for neuroprotection of the fetus." Cochrane Database Syst Rev. 2014;(12):CD010846. PMID: 25523279
- Antonio J, et al. "Part II. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?" J Int Soc Sports Nutr. 2025;22(1):2441760. PMID: 39720835
- Gordon AN, et al. "The Effects of Creatine Monohydrate Loading on Exercise Recovery in Active Women throughout the Menstrual Cycle." Nutrients. 2023;15(16):3567. PMID: 37630756
- Antonio J, et al. "Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?" J Int Soc Sports Nutr. 2021;18(1):13. PMID: 33557850
- van der Merwe J, et al. "Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players." Clin J Sport Med. 2009;19(5):399-404. PMID: 19741313
- Lak M, et al. "Does creatine cause hair loss? A 12-week randomized controlled trial." J Int Soc Sports Nutr. 2025;22(sup1):2495229. PMID: 40265319
- Naeini EK, et al. "Effect of creatine supplementation on kidney function: a systematic review and meta-analysis." BMC Nephrol. 2025;26(1):622. PMID: 41199218
- NIH Office of Dietary Supplements. Dietary Supplement Label Database. dsld.od.nih.gov (creatine labels retrieved 2026-08-30).